Duke University

This is your central portal for breaking news, the latest research and important updates from $name. Bookmark this page and check back often for updates.

Cover Story

Palliative care flourishing but ‘significant hurdles’ remain

HemOnc Today, March 25, 2020
With one in six cancer survivors reporting high-impact chronic pain that limits their life and work activities, palliative care increasingly has been…

12 medical centers form brain tumor research collaborative

March 22, 2020
Twelve institutions across the United States and Canada formed a collaborative designed to
Cover Story

Mindset Matters: Harnessing the Placebo Effect for Patient Benefit

Healio Rheumatology, March 2020
To a nonmedical professional, the placebo effect is a fairly straightforward concept: give someone a sugar pill, tell them it is medicine, they think…

How extensive should treatment be for asymptomatic adverse local tissue reaction associated with metal-on-metal hip implants?

Orthopedics Today, March 2020
The algorithm for revision surgery for after metal-on-metal THA has evolved, and symptomatic patients are encouraged to consider revision. However…

Which treatment paradigm — local or systemic therapy — best treats bilateral noninfectious uveitis?

Ocular Surgery News U.S. Edition, March 10, 2020
There are distinct advantages of systemic therapy in terms of achieving control in both eyes, at a steady state, and without the risks for cataract…
In the Journals

Link between gut microbiota, clinical outcomes generalizable among allogeneic HSCT recipients

February 26, 2020
Patterns of microbiota disruption, marked by loss of intestinal diversity and single taxa domination, appeared similar among a cohort of patients…

Hematology scholars to participate in ASH faculty development program

February 1, 2020
Gabriela S. Hobbs, MD, and Oluwatoyosi Adefunke Onwuemene, MD, MS, will participate in the American Society of Hematology-Harold Amos Medical…

Q&A: Vision training to improve athletic performance

January 16, 2020
Athletes are continually looking for ways to improve their performance and gain an advantage in training to give them a leg up on their competition. …

Key opinion leaders discuss top news from 2019

Cardiology Today, January 2020
Approximately 50% of high school students are vaping. The major product in these devices is nicotine, one of the most addicting substances known. As…
Cover Story

Systemic drugs and their ocular symptoms can complicate treatment

Ocular Surgery News U.S. Edition, January 25, 2020
Drugs that treat systemic diseases can be lifesaving, but when these drugs lead to poor ocular health or vision, the treatment paradigms can be…

Is it feasible to change the immunotherapy dose schedule for a patient in complete response?

HemOnc Today, December 25, 2019
POINT Immunotherapy represents a novel form of therapy in many ways, and it may not need to be given continuously. Currently approved checkpoint…

ASH presents Scholar Awards to fellows, junior faculty

December 22, 2019
ASH announced the recipients of its 2019 Scholar Awards. The awards — presented to hematologists in the United States and Canada who conduct…
FDA News

FDA advisory committee unanimously supports approval of tazemetostat for epithelioid sarcoma

December 18, 2019
The FDA’s Oncologic Drugs Advisory Committee, or ODAC, today voted 11-0 in favor of approval of tazemetostat for the treatment of adults with…
FDA News

FDA panel narrowly supports approval of maintenance olaparib in BRCA-mutated pancreatic cancer

December 17, 2019
An FDA panel today supported approval of olaparib as maintenance treatment for adults with deleterious or suspected deleterious germline…
FDA News

FDA approves Xtandi for metastatic castration-sensitive prostate cancer

December 17, 2019
The FDA approved enzalutamide for the treatment of metastatic castration-sensitive prostate cancer. Enzalutamide (Xtandi; Pfizer, Astellas) already…
Meeting News

Pain similar in doublet, triplet regimens for multiple myeloma

December 12, 2019
ORLANDO – The addition of venetoclax to standard of care regimens in multiple myeloma did not increase the physical burden on patients…
Meeting News

Beovu improves visual acuity in AMD, polypoidal choroidal vasculopathy

October 29, 2019
SAN FRANCISCO — Treatment with Beovu resulted in visual acuity letter gains among patients with age-related macular degeneration and polypoidal…

Breast surgeon to lead Duke Cancer Institute's clinical cancer genetics program

October 18, 2019
Carolyn Menendez, MD, FACS, has been appointed director of Duke Cancer Institute’s clinical cancer genetics program. Menendez —…
Cover Story

Catheter ablation for AF: Debate continues over benefit

Cardiology Today, October 2019
The debate on the use of catheter ablation in patients with atrial fibrillation has intensified among cardiologists after results of the anticipated…
Meeting News

Valacyclovir reduces rate of fetal CMV infection by 71%

October 9, 2019
WASHINGTON — Findings from a randomized, double-blind, placebo-controlled trial presented at IDWeek sparked hope for the use of antiviral…